A Study Investigating Medication Adherence and Persistence in Patients Taking Deferasirox Dispersible Tablets (DFX-DT) and Film-Coated Tablets (DFX-FCT) and in Patients who switched from DFX-DT to DFX-FCT (Texas Medicaid Patients)

Trial Profile

A Study Investigating Medication Adherence and Persistence in Patients Taking Deferasirox Dispersible Tablets (DFX-DT) and Film-Coated Tablets (DFX-FCT) and in Patients who switched from DFX-DT to DFX-FCT (Texas Medicaid Patients)

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2017

At a glance

  • Drugs Deferasirox (Primary)
  • Indications Iron overload
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Dec 2017 New trial record
    • 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top